fbpx

Noramco and SPI Pharma Announce Availability of New Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms – PRNewswire

Noramco and SPI Pharma Announce Availability of New Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms – PRNewswire Noramco and SPI Pharma Announce Availability of New Excipient Compatibility Study for Cannabidiol Solid Oral Dosage Forms  PRNewswire

WILMINGTON, Del., July 9, 2019 /PRNewswire/ — Noramco and SPI Pharma announced that they have completed work on an excipient compatibility study …

বাংলা简体中文繁體中文EnglishFrançaisDeutschहिन्दीItaliano日本語한국어मराठीPortuguêsਪੰਜਾਬੀРусскийEspañolSvenskaతెలుగుไทยTürkçeУкраїнськаTiếng Việt